Rejected drug may protect against toxic substance common to Alzheimer's and Parkinson's diseases
The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative ...
Aug 13, 2012
0
0